These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 22422168

  • 1. How to manage acute promyelocytic leukemia.
    Mi JQ, Li JM, Shen ZX, Chen SJ, Chen Z.
    Leukemia; 2012 Aug; 26(8):1743-51. PubMed ID: 22422168
    [Abstract] [Full Text] [Related]

  • 2. Long-term prognosis of childhood acute promyelocytic leukaemia with arsenic trioxide administration in induction and consolidation chemotherapy phases: a single-centre experience.
    Cheng Y, Zhang L, Wu J, Lu A, Wang B, Liu G.
    Eur J Haematol; 2013 Dec; 91(6):483-9. PubMed ID: 24033687
    [Abstract] [Full Text] [Related]

  • 3. Current treatment strategy of acute promyelocytic leukemia.
    Mi J.
    Front Med; 2011 Dec; 5(4):341-7. PubMed ID: 22198746
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
    Lo-Coco F, Avvisati G, Vignetti M, Thiede C, Orlando SM, Iacobelli S, Ferrara F, Fazi P, Cicconi L, Di Bona E, Specchia G, Sica S, Divona M, Levis A, Fiedler W, Cerqui E, Breccia M, Fioritoni G, Salih HR, Cazzola M, Melillo L, Carella AM, Brandts CH, Morra E, von Lilienfeld-Toal M, Hertenstein B, Wattad M, Lübbert M, Hänel M, Schmitz N, Link H, Kropp MG, Rambaldi A, La Nasa G, Luppi M, Ciceri F, Finizio O, Venditti A, Fabbiano F, Döhner K, Sauer M, Ganser A, Amadori S, Mandelli F, Döhner H, Ehninger G, Schlenk RF, Platzbecker U, Gruppo Italiano Malattie Ematologiche dell'Adulto, German-Austrian Acute Myeloid Leukemia Study Group, Study Alliance Leukemia.
    N Engl J Med; 2013 Jul 11; 369(2):111-21. PubMed ID: 23841729
    [Abstract] [Full Text] [Related]

  • 7. Combination therapy with arsenic trioxide, all-trans retinoic acid, and chemotherapy in acute promyelocytic leukemia patients with various relapse risks.
    Huang H, Qin Y, Xu R, You X, Teng R, Yang L, Xu M, Liu H.
    Leuk Res; 2012 Jul 11; 36(7):841-5. PubMed ID: 22534100
    [Abstract] [Full Text] [Related]

  • 8. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
    Quezada G, Kopp L, Estey E, Wells RJ.
    Pediatr Blood Cancer; 2008 Jul 11; 51(1):133-5. PubMed ID: 18293388
    [Abstract] [Full Text] [Related]

  • 9. What is the role of arsenic in newly diagnosed APL?
    Tallman MS.
    Best Pract Res Clin Haematol; 2008 Dec 11; 21(4):659-66. PubMed ID: 19041605
    [Abstract] [Full Text] [Related]

  • 10. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
    Zhou GB, Zhang J, Wang ZY, Chen SJ, Chen Z.
    Philos Trans R Soc Lond B Biol Sci; 2007 Jun 29; 362(1482):959-71. PubMed ID: 17317642
    [Abstract] [Full Text] [Related]

  • 11. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.
    Thirugnanam R, George B, Chendamarai E, Lakshmi KM, Balasubramanian P, Viswabandya A, Srivastava A, Chandy M, Mathews V.
    Biol Blood Marrow Transplant; 2009 Nov 29; 15(11):1479-84. PubMed ID: 19822309
    [Abstract] [Full Text] [Related]

  • 12. Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia.
    Lengfelder E, Hofmann WK, Nowak D.
    Leukemia; 2012 Mar 29; 26(3):433-42. PubMed ID: 21904379
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of acute promyelocytic leukemia without cytotoxic chemotherapy.
    Park JH, Tallman MS.
    Oncology (Williston Park); 2011 Jul 29; 25(8):733-41. PubMed ID: 21874835
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Incorporation of arsenic trioxide in induction therapy improves survival of patients with newly diagnosed acute promyelocytic leukaemia.
    Song X, Hu X, Lü S, Gao L, Chen L, Yang J, Zhang W, Wang J.
    Eur J Haematol; 2014 Jul 29; 93(1):54-62. PubMed ID: 24592821
    [Abstract] [Full Text] [Related]

  • 17. Insights into the All-trans-Retinoic Acid and Arsenic Trioxide Combination Treatment for Acute Promyelocytic Leukemia: A Meta-Analysis.
    Ma H, Yang J.
    Acta Haematol; 2015 Jul 29; 134(2):101-8. PubMed ID: 25925330
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxide.
    Sanford D, Lo-Coco F, Sanz MA, Di Bona E, Coutre S, Altman JK, Wetzler M, Allen SL, Ravandi F, Kantarjian H, Cortes JE.
    Br J Haematol; 2015 Nov 29; 171(4):471-7. PubMed ID: 26205361
    [Abstract] [Full Text] [Related]

  • 20. The expanding role of arsenic in acute promyelocytic leukemia.
    Tallman MS.
    Semin Hematol; 2008 Jul 29; 45(3 Suppl 2):S25-9. PubMed ID: 18760708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.